systems who received optimally fluoridated water; percentagepoint increases ranged from 0.3 in Alabama to 69.9 in Nevada (median: 6.2). Ten states had decreases; percentagepoint decreases ranged from 0.2 in Kentucky and North Dakota to 17.0 in Idaho (median: 4.3) ( Table 2) . Through out 1992-2006, 100% of the DC population served by com munity water systems received optimally fluoridated water.
Populations Receiving Optimally Fluoridated Public Drinking WaterUnited States, 1992-2006
Water fluoridation has been identified by CDC as one of 10 great public health achievements of the 20th century. The decline in the prevalence and severity of dental caries (tooth decay) in the United States during the past 60 years has been attributed largely to the increased use of fluoride (1) . Com munity water fluoridation is an equitable and cost-effective method for delivering fluoride to the community (2) (3) (4) . A Healthy People 2010 objective is to increase to 75% the pro portion of the U.S. population served by community water systems who receive optimally fluoridated water* (5). To update and revise previous reports on fluoridation in the United States (4) and describe progress toward the Healthy People 2010 objective, CDC analyzed fluoridation data for the period 1992-2006 from the 50 states and District of Co lumbia (DC). The results indicated that the percentage of the U.S. population served by community water systems who re ceived optimally fluoridated water increased from 62.1% in 1992, to 65.0% in 2000, and 69.2% in 2006, and those per centages varied substantially by state. Public health officials and policymakers in states with lower percentages of resi dents receiving optimal water fluoridation should consider in creasing their efforts to promote fluoridation of community water systems to prevent dental caries.
Since 1945, the U.S. Public Health Service and CDC (beginning in 1975) have tracked the number of persons in the United States receiving fluoridated water. † The U.S. Environmental Protection Agency (EPA) does not regulate water fluoridation, and EPA's Safe Drinking Water Informa tion System (SDWIS) only tracks fluoride concentrations in * Defined as a fluoride concentration of 0.7-1.2 ppm, depending on the average maximum daily air temperature in the area; optimal concentrations are set lower in warmer climates, where the populations drink more water, and higher in cooler climates. † Available at http://www.cdc.gov/nohss/fsgrowth_text.htm.
water systems with naturally occurring fluoride levels above the established regulatory maximum contaminant level (4.0 ppm § ). Water fluoridation is managed at the state level, and CDC relies on states to provide data on individual commu nity water systems (e.g., population served, fluoride concen tration, and fluoride source). During 1998-2000, CDC, in partnership with the Association of State and Territorial Den tal Directors, developed the Water Fluoridation Reporting System (WFRS) to support management and tracking of state fluoridation programs. WFRS is a voluntary system designed, in part, to make additional use of community water system data that states were already required to report to EPA as part of SDWIS.
In March 2007, CDC asked state dental directors and drink ing water administrators to validate their state data reported via WFRS for 2006. Estimates of the population served by community water systems were based on the number of house holds served (i.e., service connections) and the number of persons in each household. Some states supplemented popu lation data in WFRS with population data from SDWIS, which can differ slightly from WFRS. The percentage of the population served by community water systems who received § EPA also has set a secondary maximum contaminant level of 2.0 ppm as a precaution against possible tooth discoloration or pitting from excess fluoride exposure during the formative period for young children. Additional information is available at http://www.epa.gov/safewater/consumer/2ndstandards.html.
optimally fluoridated water was calculated by dividing the population served by community water systems with optimal fluoride levels by the total population served by community water systems. For eight states and DC, the reported 2006 total commu nity water system population estimates exceeded mid-year intercensal state population estimates (6) , which can occur when applying a standard persons-per-household factor to the number of households served. For these eight states and DC, state community water system population estimates were set equal to the intercensal state population estimates, and esti mates of the population receiving optimally fluoridated water were reduced by a factor equal to the state's intercensal popu lation estimate divided by the initially reported total state com munity water system population. National community water system population estimates were calculated by adding the state community water system population estimates after this reduction.
CDC previously published a report on fluoridation esti mates for 2000 (4) , using WFRS data reviewed by state oral health programs. At that time, state community water system populations that exceeded the state's 2000 census populations (seven states and DC) were changed to match the 2000 cen sus populations. Earlier, in calculating 1992 fluoridation esti mates, state community water system populations that exceeded state census population estimates also were changed to match 1992 intercensal state population estimates (10 states and DC). Because these two reports used the reduced state community water system populations for their calculations without making any adjustments to the populations receiving fluoridated water, the percentages potentially were overstated. This report revises the 2000 fluoridation percentage estimates, applying the same methods used to produce the 2006 esti mates, and reflecting improvements in the quality and accu racy of some WFRS state data. The 1992 fluoridation estimates could not be revised similarly because water system popula tion data from 1992 were no longer available.
In 2006, 69.2% of the U.S. population served by commu nity water systems received optimally fluoridated water (Table 1) , an increase from 62.1% in 1992, and from 65.0% in 2000 (Table 2 ). State-specific percentages in 2006 ranged from 8.4% in Hawaii to 100% in DC (median: 77.0%). In 2006, the Healthy People 2010 target of 75% had been met by 25 states and DC (Table 1) Editorial Note: Dental caries is a complex, chronic disease with multiple protective factors (e.g., dental sealants or healthy dietary practices), including fluoride (7); teeth remain at risk for decay throughout the lifespan, with older adults experi encing rates of caries similar to rates among children (8) . Com munity water fluoridation has been effective in preventing tooth decay (1) . Commercially sold bottled waters might or might not contain fluoride, and most bottled waters do not contain fluoride in optimal concentrations (9) .
WFRS data indicate that, from 1992 to 2006, the percent age of the U.S. population served by community water sys tems who received optimally fluoridated water increased from 62.1% to 69.2%. During that period, the percentage increased in most states; by 2006, half the states had reached the Healthy People 2010 target of 75%. However, the 2006 data also indi cate substantial differences among states in progress toward that target. For example, in California, the percentage of the state population served by community water systems who received optimally fluoridated water increased by 11.4 per centage points from 1992 to 2006. However, in 2006, the percentage of the California population served by commu nity water systems who received optimally fluoridated was only 27.1%, third lowest among states. A 1995 state law required community water systems in California to implement fluori dation if state funds were provided to the community; how ever, implementation has been limited by engineering and funding constraints. In Idaho, the percentage receiving opti mally fluoridated water declined by 17.0 percentage points from 1992 to 2006 because of reclassification from optimal to below optimal of a large community water system in Boise. In Louisiana, the percentage declined by 15.3 points during the same period, largely because of relocation of a substantial number of residents from areas with fluoridation to areas with out fluoridation after Hurricane Katrina. In Maine, several local referenda were passed during 1996-2004, authorizing community water systems to fluoridate; as a result, 29 com munities gained access to fluoridated water. Attainment of the Healthy People 2010 objective will require 1) recognition by policymakers and the public that dental caries remains an important public health problem and that fluoridation is an equitable and cost-effective method of addressing the problem, even in smaller populations where the per-capita cost of fluoridation is higher; 2) continuing science-based education of the public about the established safety of fluoridation; and 3) the political will to adopt new fluoridation systems in communities that are not served cur rently (10) . To overcome the challenges facing fluoridation, public health professionals at the national, state, and local level will need to enhance their promotion of fluoridation and com mit the necessary resources for equipment, personnel, and training.
Monitoring Health Effects of Wildfires Using the BioSense
System -San Diego County, California, October 2007
During October 21-26, 2007, wildfires consumed hundreds of thousands of acres and forced the evacuation of more than 300,000 persons in San Diego County, California (1). Dur ing large-scale emergencies, data are needed to assess health effects, plan response, and evaluate response adequacy (2) . This report describes some of the health effects of the wildfires based on data from the CDC BioSense system, which receives emer gency department (ED) patient chief complaint information and physician diagnosis codes from six hospitals in San Diego County. Analysis of these data indicated that ED visits for respiratory disease, especially those associated with dyspnea and asthma, increased during a 5-day fire period compared with the preceding 20 weekdays. For the six hospitals com bined, visits for dyspnea increased from 48.6 to 72.6 per day, and visits with diagnoses of asthma increased from 21.7 to 40.4 per day. Local, state, and federal public health personnel should continue collaborative efforts to expand and monitor automated surveillance systems so that timely information is available during emergencies.
BioSense is a national system that enables receipt, analysis, and visualization of electronic health-care data for public health use (3) . Data are available simultaneously to local, state, and federal public health officials and hospital personnel through BioSense, which can be accessed through the CDC Secure Data Network. Hospitals are included in the system based on their ability to supply appropriate electronic data and their willingness to participate. In October 2007, data were being received from EDs at 413 nonfederal hospitals in the United States, including six of the 19 hospitals in San Diego County. These six hospitals were located near but outside the fire and evacuation areas (Figure 1 with the number expected based on a 7-day mov ing average. A modification of the Early Aberra tion Reporting System (EARS) C-2 algorithm (5,6) is used to determine statistical significance, which is expressed as a recurrence interval (i.e., the num ber of expected days between counts as high as those observed). For this report, single-day visit counts with a recurrence interval of >100 days (analogous to p<0.01) were considered statistically significant. During October 22-30, 2007, CDC personnel monitored BioSense for evidence of health effects possibly related to the wildfires in San Diego County. These data were provided to applicable fed eral, state, and local public health officials and emer gency managers each day. CDC personnel monitored for increases in respiratory disease, gas trointestinal diseases (multiple boil-water orders had been issued), burns, and cardiac dysrhythmias (which have been associated with carbon monox ide and cyanide toxicity from smoke inhalation). Because increased activity was found primarily for respiratory diseases, data in this report are limited to the respiratory syndrome and five respiratory * BioSense is a national automated surveillance system operated by CDC that enables subsyndromes (asthma, bronchitis, chest pain, receipt, analysis, and visualization of electronic health-care data for public health use.
cough, and dyspnea).
Diseases, Ninth Revision, Clinical Modification [ICD-9-CM] codes). As part of standard procedure, diagnoses are assigned to one or more disease indicators, including 11 general syn dromes (e.g., respiratory* and gastrointestinal) and 78 more specific subsyndromes (e.g., asthma and dyspnea), on the ba sis of reference tables (4, 5) . Free-text chief complaints are parsed automatically for specified keywords and assigned to these syndromes and subsyndromes. Median times from pa tient visit to receipt of ED data at CDC are 8 hours (interquartile range [IQR] = 0.8-20.8 hours) for chief com plaints and 5 days (IQR = 1.5-8.5 days) for diagnosis codes. Once received at CDC, these data are processed and made available in BioSense within 2-3 hours. The daily count of * Syndrome definitions were created by a multi-agency working group to assist in ICD-9-CM code-based surveillance for bioterrorism-associated diseases (definitions available at http://www.bt.cdc.gov/surveillance/syndromedef/word/ syndromedefinitions.doc). The respiratory syndrome includes codes for the following: acute infection of the upper and/or lower respiratory tract (from the oropharynx to the lungs; includes otitis media); specific diagnosis of acute respiratory tract infection, such as pneumonia attributed to parainfluenza virus; acute nonspecific diagnosis of respiratory tract infection, such as sinusitis, pharyngitis, and laryngitis; and acute nonspecific symptoms of respiratory tract infection, such as cough, stridor, shortness of breath, and throat pain.
The fire period was defined as October 22-26, 2007. First, BioSense was examined for evidence of singleday increases in the daily count of visits with selected disease indicators among ED patients during the fire period. Next, pooled visit counts from the 5-day fire period were compared with a 20-day pre-fire period. Because the fire period included only weekdays, and because the average number of ED visits differed on weekdays compared with weekends, the 20 week days during September 24-October 19 were used as the prefire period. For the pooled data, the number of visits for a given indicator per hospital per day (normalized by dividing by the mean number of visits for the indicator per day for the hospital during both periods combined) in the pre-fire versus fire period were compared by using the nonparametric KruskalWallis test.
Visits for and diagnoses of asthma increased on October 22, the day after the wildfire started, were significantly high for 3 days (October 22-24), and declined on October 25 after a change in wind speed and direction improved conditions ( Figure 2 ). Asthma chief complaints also were significantly high on 1 day (October 14) during the pre-fire period. Peak asthma chief complaint and diagnosis visit counts were higher during the fire period than they had been in >6 months. Data from individual hospitals indicated that asthma chief complaints and diagnosis visit counts were each high on at least 1 day during the fire period at four of the six hospitals.
Analysis of pooled chief complaint visit counts indicated that the mean number of ED visits per day was 653.0 during the pre-fire period, compared with 680.8 during the fire period (p=0.2). Comparison of chief complaint visit counts in the pre-fire versus fire periods showed significant increases for the respiratory syndrome (from 134.1 to 163.2 mean visits per day; 29.2 excess visits per day), asthma (12.4 excess visits per day), and dysp nea (24.1 excess visits per day) (Table) .
Comparison of diagnosis codes during the pre-fire versus fire periods showed increases in visits for the respiratory syn drome, asthma, and dyspnea, with 30.3, 18.7, and 7.3 excess visits per day, respectively. ¶ Kruskal-Wallis test. ** Free-text chief complaints are parsed for specified keywords and assigned to syndromes and subsyndromes. † † Syndrome definitions were created by a multi-agency working group to assist in International Classification of Diseases, Ninth Revision, Clinical Modifi cation (ICD-9-CM) code-based surveillance for bioterrorism-associated diseases (definitions available at http://www.bt.cdc.gov/surveillance/syndromedef/ word/syndromedefinitions.doc). The respiratory syndrome includes codes for the following: acute infection of the upper and/or lower respiratory tract (from the oropharynx to the lungs; includes otitis media); specific diagnosis of acute respiratory tract infection, such as pneumonia attributed to parainfluenza virus; acute nonspecific diagnosis of respiratory tract infection, such as sinusitis, pharyngitis, and laryngitis; and acute nonspecific symptoms of respiratory tract infection, such as cough, stridor, shortness of breath, and throat pain. § § ICD-9-CM codes included in the respiratory syndrome available at http://www.bt.cdc.gov/surveillance/syndromedef/word/syndromedefinitions.doc. Other codes are as follows: asthma, 493; bronchitis, 466 and 490; chest pain, 786.5; cough, 786.2; and dyspnea, 786.0.
Editorial Note: Community smoke exposures resulting from wildfires have been associated with increased ED and hospital admissions for chronic obstructive pulmonary disease, bron chitis, asthma, and chest pain (7) (8) (9) . Therefore, CDC recom mends that persons with asthma take precautions to minimize exposure to wildfire smoke (10) . In the San Diego County wildfires of October 2007, substantial numbers of adverse health effects likely were avoided by timely evacuation orders (implemented with an emergency telephone notification sys tem and follow-up visits by law enforcement personnel to ensure compliance), school closures, health communications, and other measures implemented by local authorities. On October 25, a decrease in wind speed allowed containment of the fires, and a change in wind direction blew smoke away from populated areas. Nevertheless, this analysis indicated increased ED visits for respiratory indicators, especially asthma, in a subset of San Diego hospitals. Postdisaster health surveillance often is implemented on an ad hoc basis, sometimes employing inconsistent methods and event definitions (2) . If available in the affected area, existing electronic biosurveillance systems can provide data immedi ately (i.e., without the delay experienced when an ad hoc sys tem is initiated) and provide data from the predisaster period for comparison.
The findings in this report are subject to at least two limita tions. First, whether the six nonfederal San Diego County hospitals that participate in BioSense are representative of other area hospitals is uncertain. Second, misclassifications might have occurred because of limitations of patient-reported chief complaints, which are subjective, and diagnosis codes, which have well-recognized limitations. Moreover, the same patient might have made more than one visit on different days, and the same visit might have been classified as showing more than one disease indicator (e.g., a visit with a chief complaint of "asthma and shortness of breath" would have been included in both the asthma and dyspnea categories, but counts from these two categories were analyzed separately and not added together).
BioSense is undergoing several changes that will expand its population coverage, provide greater access to additional data types (e.g., microbiology laboratory data), increase capabili ties for collaboration with state and local health departments, and upgrade its technical capabilities. A current strength is the ability to provide simple measures of illnesses, such as asthma associated with wildfires, which can be derived from chief complaints or diagnoses and affect large populations. The same data streams can be used to monitor infections, injuries, and chronic diseases; conduct routine surveillance (e.g., for seasonal influenza); and monitor adverse health effects during large gatherings (e.g., the World Series) and during disasters. These systems can be valuable to state and local officials who are primarily responsible for emergency response and disaster management. Especially when an inci dent involves multiple jurisdictions, having an aggregate, cen tralized view of real-time data analyzed and presented with consistent methods can be useful to assess health effects, evalu ate response adequacy, and determine whether additional action is required.
Disparities in Secondhand Smoke
Exposure -United States,
1988-1994 and 1999-2004
No level of exposure to secondhand smoke (SHS) is safe (1). Breathing SHS can cause heart disease and lung cancer in nonsmoking adults and increases the risk for sudden infant death syndrome, acute respiratory infections, middle-ear dis ease, and exacerbation of asthma in children (1-3). In the United States, exposure to SHS declined approximately 70% from the late 1980s through 2002, most likely reflecting wide spread implementation of laws and policies prohibiting smok ing in indoor workplaces and public places during this period (1, 4) . Although the major sources of SHS exposure for non smoking adults are the home and workplace, the primary source of SHS exposure for children is the home (1); there fore, eliminating smoking in workplaces and public places is less likely to reduce children's exposure to SHS. This report examines changes in the prevalence of self-reported SHS exposure at home and changes in any exposure, as measured by serum cotinine (a biologic indicator of SHS exposure), in nonsmoking children, adolescents, and adults. The analysis was conducted using data from the 1988-1994 and 1999-2004 National Health and Nutrition Examination Surveys (NHANES). The results indicated that self-reported SHS exposure at home and SHS exposure as measured by serum cotinine declined significantly (i.e., by 51.2% and 44.7%, respectively) in the U.S. population from 1988-1994 to 1999-2004; however, the decline was smaller for persons aged 4-11 years and 12-19 years. These results underscore the need to continue surveillance of SHS exposure and to focus on strategies to reduce children's SHS exposure.
NHANES consists of a series of cross-sectional surveys designed to monitor the health and nutritional status of the U.S. civilian, noninstitutionalized population. Participants were selected through a complex, multistage probability design and completed a household interview and standard ized physical examination in specially equipped mobile examination centers. Subgroups of the population, including blacks and Mexican Americans, were oversampled to provide reliable estimates for these groups. For persons aged >4 years in 1988-1994 and aged >3 years in 1999-2004, blood was collected by venipuncture and serum cotinine levels were mea sured in blood samples using a high performance liquid chro matography mass spectrometry method at CDC. Serum cotinine levels indicate exposure to nicotine during the past 3-4 days (4).
The study sample was limited to nonsmokers aged >4 years. Nonsmokers were defined as respondents with serum cotinine <10 ng/mL. Respondents aged >12 years were excluded if, at the examination, they reported tobacco or nicotine use dur ing the past 5 days. Serum cotinine measures were available for 83.7% (N = 22,377) of examined persons aged >4 years in 1988-1994 and for 89.9% (N = 22,994) in 1999-2004.
The final sample size for nonsmokers was 17,261 in 1988-1994 and 17,931 in 1999-2004. Exposure to SHS in non smokers was defined as a detectable serum cotinine level of >0.05 ng/mL (i.e., the laboratory limit of detection during 1988-1994 and 1999-2000) . Serum cotinine was not used as a continuous variable because approximately 50% of re sults were below the laboratory limit of detection in the study population during 1999-2000. Exposure to SHS inside the home was defined as the presence of at least one household member who smoked cigarettes inside the home.* The percentage of persons with self-reported home SHS exposure, the percentage with detectable serum cotinine, strati fied by age group (4-11 years, 12-19 years, and >20 years), race/ethnicity (non-Hispanic white, non-Hispanic black, and Mexican American), and other demographic characteristics were calculated. Data analyses accounted for the complex sur vey design, differential probabilities of sample selection, nonresponse, and sample noncoverage. Differences between population subgroups and between periods were evaluated using a univariate t-statistic. All significance tests were twosided using p<0.05 as the level of statistical significance.
The percentage of the U.S. nonsmoking population aged >4 years with self-reported home SHS exposure declined from 20.9% in 1988-1994 to 10.2% in 1999-2004 (Table) . Simi larly, the percentage of the nonsmoking population with detectable serum cotinine declined significantly, from 83.9% in 1988-1994 to 46.4% in 1999-2004. The decline was sta tistically significant within all subgroups of the study popula tion for both measures of exposure.
The percentage of nonsmokers with detectable serum cotinine was uniformly high for all age groups during 1988-1994. The percentage decreased for all age groups during 1999-2004, and remained highest for those aged 4-11 years (60.5%) and those aged 12-19 years (55.4%) compared with those aged >20 years (42.2%). The decline in the prevalence of detectable serum cotinine was 28.1% for those aged 4-11 years, 35.1% for those aged 12-19 years, and 49.5% for those aged >20 years.
During 1988-1994, non-Hispanic blacks were more likely than non-Hispanic whites and Mexican Americans to have detectable serum cotinine (93.7%, 83.2%, and 77.7%, respectively). However, by 1999-2004, the gap had increased between non-Hispanic blacks with detectable serum cotinine (70.5%) and non-Hispanic whites (43.0%) and Mexican Americans (40.0%). The percentage of nonsmokers with de tectable serum cotinine was inversely associated with family income in both periods, and the decline over time was smaller * As determined by responses to questions in NHANES 1988 NHANES -1994 for the lowest income group compared with the higher in come groups. Although the percentage decrease in home SHS exposure from 1988-1994 to 1999-2004 was seen for persons of all ages, it was smaller in children, especially those aged 4-11 years, compared with those aged >20 years. For SHS exposure in the home, the declines were 37.7%, 44.9%, and 59.8% among those aged 4-11 years, 12-19 years, and >20 years, respectively.
During both periods, prevalence of SHS exposure in the home was highest among non-Hispanic blacks and for per sons with lower incomes. For both periods, self-reported home SHS exposure was not significantly different in males than in females, but a higher percentage of males had detect able serum cotinine than did females. Documented reductions in SHS exposure since the late 1980s have been attributed to widespread implementation of laws and policies restricting or eliminating exposure in work places and public places during this period (4, 5) . Addition ally, the prevalence of cigarette smoking has decreased during this period, from 28% in 1988 to 21% in 2004 (6), which likely reduced SHS exposure, particularly in the home.
A recent study reported that the proportion of households that have rules against smoking in the home has increased since the early 1990s, from 43% in 1992-1993 to 72% in 2003 (7) . That parallels the decline in the prevalence of SHS exposure in the home reported in this study. However, a higher prevalence of SHS exposure was still evident in the groups aged 4-11 years and 12-19 years compared with the group aged >20 years during 1999-2004, a pattern that has been noted previously (4) . Additionally, the disparity in exposure between those aged 4-11 years and 12-19 years compared with those aged >20 years has widened since the early 1990s. The major source of SHS exposure for those aged 4-11 years is from parental smoking in the home (8) .
This analysis determined that the decrease in home SHS exposure from 1988-1994 to 1999-2004 was similar for nonHispanic blacks and non-Hispanic whites. For SHS exposure as measured by serum cotinine, however, the relative decline was nearly twice as large for non-Hispanic whites compared with non-Hispanic blacks. Previous studies have noted that non-Hispanic blacks have higher serum cotinine levels than non-Hispanic whites, both for smokers and nonsmokers, and that differences in nicotine metabolism might partially explain this disparity (4) . At least one study that assessed mul tiple sources of SHS exposure reported that among nonsmok ers, non-Hispanic blacks had higher levels of SHS exposure than other groups, which explained the higher serum cotinine levels in non-Hispanic blacks (9) . Information about other sources of exposure to SHS is needed to interpret the dispar ity between non-Hispanic whites and non-Hispanic blacks in the percentage with detectable serum cotinine in the NHANES surveys.
The findings in this report are subject to at least three limi tations. First, the assessment of self-reported home SHS exposure is based only on information about household mem bers who smoke inside the home. Information about smok ing inside the home by visitors was not collected. Second, information is not available about potential SHS exposure in locations outside of the home, including automobiles, work places, public places, and other homes. Information about smoker behaviors to protect nonsmokers from SHS exposure in the home also was not obtained. Finally, measurement of serum cotinine levels in nonsmokers only provides a measure of overall SHS exposure, regardless of the sources of exposure.
The U.S. Surgeon General has concluded that protecting nonsmokers from SHS exposure can only be accomplished by completely eliminating smoking in indoor places (1) . SHS exposure among nonsmokers has declined markedly during the past 2 decades, largely through implementation of laws and policies that prohibit smoking in workplaces and public places (4, 6) . Despite this success in reducing SHS exposure, the results of this study underscore the need for ongoing pre vention efforts to reduce SHS exposure with strategies that focus on protection for those at greatest risk (10). Figure 2 on page 35. The title for the figure should read, "Number of imported malaria cases and estimated relative case rates* among U.S. residents, by country of acquisitionUnited States, 2006," and the fourth sentence of the footnote should read, "The number of cases of malaria among U.S. resident travelers attributable to each country is displayed next to the country name in parentheses." * Results are based on responses to the questions "During the past 30 days, how often did you feel 1) so sad that nothing could cheer you up, 2) nervous, 3) restless or fidgety, 4) hopeless, 5) that everything was an effort, or 6) worthless?" Response codes for the six items for each person were summed to yield a point value on a 0-24-point scale. A value of 13 or more was used to define serious psychological distress. † Estimates are based on household interviews of a sample of the civilian, noninstitutionalized U.S. population. § 95% confidence interval.
In 2007, among all adults >18 years, women were significantly more likely than men to have experienced symptoms of serious psychological distress during the past 30 days. By age group, adults aged 45-64 years were more likely than adults aged >65 years to have experienced these symptoms. Overall, approximately 3% of the U.S. adult population had experienced symptoms of serious psychological distress during the past 30 days. Table II . § § Updated monthly from reports to the Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. Implementation of HIV reporting influences the number of cases reported. Updates of pediatric HIV data have been temporarily suspended until upgrading of the national HIV/AIDS surveillance data management system is completed. Data for HIV/AIDS, when available, are displayed in Table IV , which appears quarterly. ¶ ¶ Updated weekly from reports to the Influenza Division, National Center for Immunization and Respiratory Diseases. Eighty-four cases occurring during the 2007-08 influenza season have been reported. *** No measles cases were reported for the current week. † † † Data for meningococcal disease (all serogroups) are available in Table II . § § § In 2008, Q fever acute and chronic reporting categories were recognized as a result of revisions to the Q fever case definition. Prior to that time, case counts were not differentiated with respect to acute and chronic Q fever cases. ¶ ¶ ¶ No rubella cases were reported for the current week. **** Updated weekly from reports to the Division of Viral and Rickettsial Diseases, National Center for Zoonotic, Vector-Borne, and Enteric Diseases.
SOURCE:
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July 11, 2008 -11  26  102  448  -0  0  ---0  0  --Puerto Rico  116  116  612  3, 6  24  58  501  562  94  96  227  2,528  2,839  1  3  12  83  103  Connecticut  -6  18  144  155  61  46  199  1,100  1,054  -0  9  19  27  Maine§   4  3  10  61  67  1  2  7  48  61  -0  3  8  7  Massachusetts  -9  27  157  238  31  45  127  1,134  1,388  -1  5  36  53  New Hampshire  -1  4  46  10  1  2  6  64  84  -0  2  6  10  Rhode Island§   -1  15  34  28  -6  13  168  221  -0  2  7  5  Vermont§   2  3  9  59  64  -1  5  14  31  1  0  3 2  3  11  59  63  87  80  167  2,335  2,140  -0  3  3  5  Louisiana  -1  14  13  45  -181  384  3,586  5,666  -0  2  3  3  Oklahoma  2  3  35  39  52  44  94  171  2,240  2,463  -1  21  54  46  Texas§   N  0  0  N  N  -643 1,102 16,016 15,014  -0  3  5  5   Mountain  17  30  68  590  693  91  238  330  5,369  6,981  1  5  14  186  158  Arizona  -3  11  51  94  7  80  130  1,598  2,610  -2  11  83  62  Colorado  10  11  26  228  224  43  59  91  1, Alaska  -2  5  35  31  7  10  24  248  264  -0  4  11  5  California  18  38  91  888  1,047  193  555  683 13,151 16,533  -0  4  15  29  Hawaii  1  1  5  16  42  3  11  22  291  350  -0  2  13  6  Oregon§   6  9  19  207  196  6  24  63  649  569  -1  4  34  41  Washington  13  8  87  153  200  -24  97  17  2,002  1  0  3  3  1 American Samoa Rico  -2  31  39  147  7  5  23  135  168  -0 Table I . § Contains data reported through the National Electronic Disease Surveillance System (NEDSS). 3  2  7  53  55  -1  6  25  63  -3  14  37  50  Connecticut  3  0  3  14  8  -0  5  9  24  -1  4  12  8  Maine§   -0  1  4  1  -0  2  8  3  -0  2  1  1  Massachusetts  -1  5  18  28  -0  3  3  26  -0  3  1  21  New Hampshire  -0  2  5  10  -0  1  1  4  -0  2  5  1  Rhode Island§   -0  2  11  6  -0  3  3  5  -0  5  14  16  Vermont§   -0  1  1  2  -0  1  1  1  -0  2 12  9  17  183  243  4  16  60  431  540  3  8  28  189  188  D e l a w a r e  -0  1  4  3  -0  3  6  9  -0  2  5  6  District of Columbia  -0  0  ---0  0  ---0  1  6  7  Florida  3  3  8  76  72  2  6  12  169  177  1  3  10  73  69  Georgia  -1  3  24  43  1  3  8  62  75  -1  3  12  21  Maryland§   2  1  3  20  42  -2  6  36  62  1  2  6  44  32  North Carolina  7  0  9  33  25  -0  17  48  75  -0  7 -1  3  20  13  -1  4  23  35  -0  2  8  3  Washington  -1  7  33  19  -1  9  19  23  -0  3  14  8 American Table I . § Contains data reported through the National Electronic Disease Surveillance System (NEDSS). -0  1  ---0  1  ---0  1  6  7  Louisiana  -0  0  -2  -0  1  -13  -0  3  12  23  Oklahoma  -0  1  ---0  4  2  3  -0  5  10  14  Texas§   -1  10  25  31  -1  60  14  30  -1  7  36  25   Mountain  -0  3  14  15  -1  5  13  32  -1  4  33 45 4  4  8  122  32  3  3  10  65  68  3  4  17  163  154  Alaska  -0  2  1  2  -0  2  3  2  -0  2  3  1  California  4  3  7  103  27  3  2  8  52  44  -3  17  119  113  Hawaii  N  0  0  N  N  -0  1  2  2  -0  2  1  4  Oregon§   -0  4  1 8  3  -0  2  4  1 2  1  0  3  2 2  2 2  Washington  -0  7  ---0  3  4  8  2  0  5  18  14 American Samoa -0  1  2  7  -0  0  ---0  2  2  2  Florida  7  3  9  97  119  -0  28  71  128  -0  3  3  4  Georgia  -0  3  19  27  21  6  37  187  124  3  0  6  13  37  Maryland†   -1  6  32  65  -9  18  221  209  2  1  6  21  27  North Carolina  -0  38  76  180  10  9  16  251  261  55  0  96  78 2  19  198  395  488  -9  40  53  595  -2  153  70  39  Arkansas†   -2  17  36  99  -1  6  36  14  -0  15  8  7  Louisiana  -0  2  3  13  -0  2  -3  -0  2  2  1  Oklahoma  -0  26  13  2  -0  32  16  45  -0  132  54  21  Texas†   2  18  179  343  374  -4  34  1  533  -1  8  6  10   Mountain  8  19  37  450  579  -2  8  30  23  -0  2  11  19  Arizona  -3  10  107  150  N  0  0  N  N  -0  2  5  3  Colorado  4  4  13  76 146 Delaware  -2  8  62  64  -0  2  7  10  -0  2  7  5  District of Columbia  -1  4  23  30  1  0  1  6  --0  3  7  10  Florida  120  92  181  1,952  1,780  3  2  18  85  70  12  24  75  478  1,369  Georgia  33  37  86  689  706  4  1  6  29  33  12  27  47  658  881  Maryland §   19  13  50  238  234  -1  4  22  20  26  3  19  232  46  Louisiana  -8  44  80  329  -0  1  -6  -5  17  78  281  Oklahoma  19  11  72  267  178  1  0  14  15  12  5  3  32  54  50  Texas§   -56  794  934  843  -3  11  52  79  55  39  702  1,375  561   Mountain  33  56  87  1,378  1,174  10  8  42  182  183  11  18  40  355  372  Arizona  16  17  40  406  380  4  1  8  33  55  9  9  30  165  185  Colorado  10  11  44  398  273  2  2  17  47  32  1  2  6  43  55  Idaho§   2  3  10  77  59  2  2  16  38  35  -0  2  5  6  Montana§   -1  10  39  45  -0  3  14  --0  1  2  13  Nevada§   2  5  12  105  127  2  0  3  13  14  -2  13  104  15  New Mexico§   -6  27  193  122  -0  5  16  22  -1  6  22  59  Utah  3  5  17  138  126  -1  9  17  25  1  1  5  11  14  Wyoming§   -1  5  2 2  4 2  -0  1  4  --0  2  3  2 5   Pacific  62  110  399  2,152  2,491  8  9  40  141  161  5  30  79  586  559  Alaska  1  1  5  25  46  -0  1  3  --0  1  -7  California  39  76  286  1,566  1,864  4  5  34  83  90  5  26  61  507  448  Hawaii  2  5  14  107  126  -0  5  5  15  -1  43  21  16  Oregon§   1  6  15  179  167  1  1  11  17  19  -1  5  24  34  Washington  19  12  103  275  288  3  1  13  33  37  -2  20  34  54 American Samoa - N  3  8  17  226  164  Kentucky  1  1  4  44  17  -0  2  8  2  1  1  7  46  34  Mississippi  -0  3  1  30  -0  3  -4  2  2  15  74  57  Tennessee§   -3  12  115  75  2  1  3  23  16  10  8  14  195  154 W.S. Central  -1  5  26  50  -0  2  7  7  -39  62  984  891  Arkansas§   -0  2  9  1  -0  1  2  2  -2  19  72  57  Louisiana  -0  5  17  49  -0  2  5  5  -10  22  189  236  Oklahoma  N  0  0  N  N  N  0  0  N  N  -1  5  42  34  Texas§   -0  0  ---0  0  ---25  49  681  564   Mountain  -1  6  19  26  -0  2  4  9  4  9  29  194  212  Arizona  -0  0  ---0  0  ---5  21  78  111  Colorado  -0  0  ---0  0  --2  1  7  59  23  Idaho 0  18  1  19  -0  23  2  32  Alaska  2  1  4  33  24  -0  0  ---0  0  --California  -0  0  ---0  18  1  19  -0  20  2  30  Hawaii  -0  0  ---0  0  ---0 ---------------Guam  -2  17  55  180  -0  0  ---0  0  --Puerto Rico  1  10  37  259  440  -0  0  ---0 for California serogroup, eastern equine, Powassan, St. Louis, and western equine diseases are available in Table I . Not notifiable in all states. Data from states where the condition is not notifiable are excluded from this table, except in 2007 for the domestic arboviral diseases and influenzaassociated pediatric mortality, and in 2003 for SARS-CoV. Reporting exceptions are available at http://www.cdc.gov/epo/dphsi/phs/infdis.htm. ¶ Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
New England
- 0 0 - - - 0 1 3 3 - 0 0 - - C . N . M . I . - - - - - - - - - - - - - - - Guam - 0 1 - 1 - 1 12 43 69 - 0 1 - - Puerto
- 0 2 - - - 0 1 - - - 0 2 - - South Dakota - 0 1 2 4 - 0 2 - 3 - 0 1 1 3
S. Atlantic
Samoa - 0 0 - - - 0 0 - 14 N 0 0 N N C . N . M . I . - - - - - - - - - - - - - - - Guam - 0 0 - - - 0 1 - 2 - 0 0 - - Puerto Rico -A r i z o n a - 0 1 2 - - 0 1 5 6 - 0 2 5 1 1 Colorado - 0 1 2 - - 0 2 3 12 - 0 2 8 15 Idaho § - 0 2 4 4 - 0 2 - - - 0 2 2 4 Montana § - 0 2 2 1 - 0 1 - 2 - 0 1 4 1 Nevada § - 0 2 1 6 - 0 3 4 2 - 0 2 6 3 New Mexico § - 0 2 2 3 - 0 1 1 1 - 0 1 4 2 U t a h - 0 1 - 1 - 0 1 - 9 - 0 2 2 7 Wyoming § - 0 1 1 - - 0 0 - - - 0 1 2 2
Pacific
N 0 0 N N - 0 0 - - - 0 0 - - C . N . M . I . - - - - - - - - - - - - - - - Guam - 0 0 - - - 0 1 1 - - 0 0 - - Puerto Rico N 0 0 N N - 0 1 1 1 - 0 1 2 6 U.S. Virgin Islands N 0 0 N N - 0 0 - - - 0 0 - - C.N.- 0 0 - - - 0 2 - - Idaho † - 0 4 1 8 2 5 - 0 4 - - - 0 1 - 2- 0 0 - - N 0 0 N N American Samoa - 0 0 - - N 0 0 N N N 0 0 N N C . N . M . I . - - - - - - - - - - - - - - - Guam - 0 0 - - - 0 0 - - N 0 0 N N Puerto Rico - 0 0 - - 1 1 5 30 26 N 0 0 N N U.S. Virgin Islands - 0 0 - - N 0 0 N N N 0 0 N N C.N.0 1 1 - - 0 0 - - - 0 1 1 3 C . N . M . I . - - - - - - - - - - - - - - - Guam - 0 2 8 11 - 0 0 - - -
